Your browser doesn't support javascript.
loading
ß-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.
Eiring, A M; Khorashad, J S; Anderson, D J; Yu, F; Redwine, H M; Mason, C C; Reynolds, K R; Clair, P M; Gantz, K C; Zhang, T Y; Pomicter, A D; Kraft, I L; Bowler, A D; Johnson, K; Partlin, M Mac; O'Hare, T; Deininger, M W.
Affiliation
  • Eiring AM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Khorashad JS; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Anderson DJ; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Yu F; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Redwine HM; Beijing Tsinghua Chang Gung Hospital, Tsinghua University, Beijing, China.
  • Mason CC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Reynolds KR; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Clair PM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Gantz KC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Zhang TY; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Pomicter AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Kraft IL; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Bowler AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Johnson K; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Partlin MM; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • O'Hare T; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Deininger MW; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
Leukemia ; 29(12): 2328-37, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26202934
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Protein Kinase Inhibitors / Beta Catenin Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Protein Kinase Inhibitors / Beta Catenin Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: United States